Data / Form D filings / Vantis Vascular, Inc.
Vantis Vascular, Inc.: Form D filings
Vantis Vascular, Inc., a company in San Jose, CA, filed 6 Form D notices with the SEC between 2018 and 2026. The latest, on July 10, 2026, reports $18.6 million sold of a $21.5 million offering to 123 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2570 N 1ST STREET SUITE 200, San Jose, CA, 95131
- Phone
- (833) 852-3001
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1761882
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | New notice | $21,500,000 | $18,639,500 | $2,860,500 | 123 | Jun 26, 2026 | sec.gov |
| Oct 10, 2024 | New notice | $22,199,202 | $14,338,798 | $7,860,404 | 114 | Sep 30, 2024 | sec.gov |
| Feb 4, 2022 | New notice | $8,023,666 | $7,043,766 | $979,900 | 73 | Jan 27, 2022 | sec.gov |
| Sep 7, 2021 | New notice | $800,000 | $503,500 | $296,500 | 17 | Aug 23, 2021 | sec.gov |
| Dec 14, 2020 | New notice | $1,000,000 | $700,000 | $300,000 | 20 | Dec 1, 2020 | sec.gov |
| Dec 18, 2018 | New notice | $1,750,000 | $485,000 | $1,265,000 | 14 | Dec 7, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tim Fischell | Executive Officer, Director | |
| Frank Saltiel | Executive Officer, Director | |
| Len Pinchuk | Director | |
| Jason Turner | Executive Officer, Director | |
| Marc Monahan | Executive Officer | |
| Mike Mirizzi | Executive Officer | |
| Gary McCord | Executive Officer |
Other companies in California that filed recently
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
- Angle Health, Inc. $591.5 million · Oct 29, 2026
- Agilis Medical, Inc. $4 million · Oct 28, 2026
- Bridgeview Innovations, Inc. $10.3 million · Oct 28, 2026
Every Form D from the week of Jul 6, 2026 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Vantis Vascular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.